148 related articles for article (PubMed ID: 9269834)
1. Ductal carcinoma in situ of the breast: reproducibility of histological subtype analysis.
Scott MA; Lagios MD; Axelsson K; Rogers LW; Anderson TJ; Page DL
Hum Pathol; 1997 Aug; 28(8):967-73. PubMed ID: 9269834
[TBL] [Abstract][Full Text] [Related]
2. Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.
Poller DN; Silverstein MJ; Galea M; Locker AP; Elston CW; Blamey RW; Ellis IO
Mod Pathol; 1994 Feb; 7(2):257-62. PubMed ID: 7911998
[TBL] [Abstract][Full Text] [Related]
3. Relationship of a new histological categorization of ductal carcinoma in situ of the breast with size and the immunohistochemical expression of p53, c-erb B2, bcl-2, and ki-67.
Mack L; Kerkvliet N; Doig G; O'Malley FP
Hum Pathol; 1997 Aug; 28(8):974-9. PubMed ID: 9269835
[TBL] [Abstract][Full Text] [Related]
4. Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening Pathology.
Sloane JP; Amendoeira I; Apostolikas N; Bellocq JP; Bianchi S; Boecker W; Bussolati G; Coleman D; Connolly CE; Dervan P; Eusebi V; De Miguel C; Drijkoningen M; Elston CW; Faverley D; Gad A; Jacquemier J; Lacerda M; Martinez-Penuela J; Munt C; Peterse JL; Rank F; Sylvan M; Tsakraklides V; Zafrani B
Hum Pathol; 1998 Oct; 29(10):1056-62. PubMed ID: 9781641
[TBL] [Abstract][Full Text] [Related]
5. Prognostic classification of breast ductal carcinoma-in-situ.
Silverstein MJ; Poller DN; Waisman JR; Colburn WJ; Barth A; Gierson ED; Lewinsky B; Gamagami P; Slamon DJ
Lancet; 1995 May; 345(8958):1154-7. PubMed ID: 7723550
[TBL] [Abstract][Full Text] [Related]
6. Cytological and architectural heterogeneity in ductal carcinoma in situ of the breast.
Quinn CM; Ostrowski JL
J Clin Pathol; 1997 Jul; 50(7):596-9. PubMed ID: 9306942
[TBL] [Abstract][Full Text] [Related]
7. A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): correlation with grade of associated invasive carcinoma.
Douglas-Jones AG; Gupta SK; Attanoos RL; Morgan JM; Mansel RE
Histopathology; 1996 Nov; 29(5):397-409. PubMed ID: 8951484
[TBL] [Abstract][Full Text] [Related]
8. Reproducibility of new classification schemes for the pathology of ductal carcinoma in situ of the breast.
Bethwaite P; Smith N; Delahunt B; Kenwright D
J Clin Pathol; 1998 Jun; 51(6):450-4. PubMed ID: 9771444
[TBL] [Abstract][Full Text] [Related]
9. Pathologists' agreement with experts and reproducibility of breast ductal carcinoma-in-situ classification schemes.
Wells WA; Carney PA; Eliassen MS; Grove MR; Tosteson AN
Am J Surg Pathol; 2000 May; 24(5):651-9. PubMed ID: 10800983
[TBL] [Abstract][Full Text] [Related]
10. [Ductal hyperplasia and ductal carcinoma in situ. Definition--classification--differential diagnosis].
Böcker W; Decker T; Ruhnke M; Schneider W
Pathologe; 1997 Jan; 18(1):3-18. PubMed ID: 9157402
[TBL] [Abstract][Full Text] [Related]
11. A proposal for the histopathological diagnosis of ductal carcinoma in situ of the breast.
Moriya T; Kasami M; Akiyama F; Ichihara S; Kurosumi M; Tsuda H; Umemura S; Akashi-Tanaka S; Imamura H; Iwase H; Shin E; Harada Y; Mitsuyama S; Ohuchi N
Breast Cancer; 2000; 7(4):321-5. PubMed ID: 11114858
[TBL] [Abstract][Full Text] [Related]
12. Ductal carcinoma in situ treated with lumpectomy and irradiation: histopathological analysis of 49 specimens with emphasis on risk factors and long term results.
Sneige N; McNeese MD; Atkinson EN; Ames FC; Kemp B; Sahin A; Ayala AG
Hum Pathol; 1995 Jun; 26(6):642-9. PubMed ID: 7774895
[TBL] [Abstract][Full Text] [Related]
13. Classification of duct carcinoma in situ (DCIS) with a characterization of high grade lesions: defining cohorts for chemoprevention trials.
Lagios MD
J Cell Biochem Suppl; 1996; 25():108-11. PubMed ID: 9027606
[TBL] [Abstract][Full Text] [Related]
14. Cytologic diagnosis and grading of ductal carcinoma in situ.
McKee GT; Tildsley G; Hammond S
Cancer; 1999 Aug; 87(4):203-9. PubMed ID: 10455208
[TBL] [Abstract][Full Text] [Related]
15. Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions.
Lennington WJ; Jensen RA; Dalton LW; Page DL
Cancer; 1994 Jan; 73(1):118-24. PubMed ID: 8275415
[TBL] [Abstract][Full Text] [Related]
16. Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ.
Sneige N; Lagios MD; Schwarting R; Colburn W; Atkinson E; Weber D; Sahin A; Kemp B; Hoque A; Risin S; Sabichi A; Boone C; Dhingra K; Kelloff G; Lippman S
Hum Pathol; 1999 Mar; 30(3):257-62. PubMed ID: 10088542
[TBL] [Abstract][Full Text] [Related]
17. Ductal carcinoma in situ (DCIS) in the male breast: a morphologic study of 84 cases of pure DCIS and 30 cases of DCIS associated with invasive carcinoma--a preliminary report.
Hittmair AP; Lininger RA; Tavassoli FA
Cancer; 1998 Nov; 83(10):2139-49. PubMed ID: 9827718
[TBL] [Abstract][Full Text] [Related]
18. Mammographic pattern of microcalcifications in the preoperative diagnosis of comedo ductal carcinoma in situ: histopathologic correlation.
Hermann G; Keller RJ; Drossman S; Caravella BA; Tartter P; Panetta RA; Bleiweiss IJ
Can Assoc Radiol J; 1999 Aug; 50(4):235-40. PubMed ID: 10459309
[TBL] [Abstract][Full Text] [Related]
19. Fine-needle aspiration cytology of ductal hyperplasia with and without atypia and ductal carcinoma in situ.
Sneige N; Staerkel GA
Hum Pathol; 1994 May; 25(5):485-92. PubMed ID: 8200642
[TBL] [Abstract][Full Text] [Related]
20. Interobserver variability in the classification of proliferative breast lesions by fine-needle aspiration: results of the Papanicolaou Society of Cytopathology Study.
Sidawy MK; Stoler MH; Frable WJ; Frost AR; Masood S; Miller TR; Silverberg SG; Sneige N; Wang HH
Diagn Cytopathol; 1998 Feb; 18(2):150-65. PubMed ID: 9484645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
